Myelodysplastic syndromes (MDS): An international practice and treatment survey.

被引：0
|
作者：
List, AF [1 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Hematol Malignancies Program, Tampa, FL USA
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2534
引用
收藏
页码：712A / 712A
页数：1
相关论文
共 50 条
  • [1] CLASSIFICATION AND TREATMENT OF MYELODYSPLASTIC SYNDROMES (MDS)
    CATOVSKY, D
    MYELODYSPLASTIC SYNDROMES : PATHOPHYSIOLOGY AND TREATMENT, 1988, 783 : 3 - 3
  • [2] Cyclosporin A in the treatment of myelodysplastic syndromes (MDS)
    Shirin, AD
    Volkova, MA
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 416 - 416
  • [3] Treatment of Lower Risk Myelodysplastic Syndromes MDS
    Komrokji, Rami
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S69 - S70
  • [4] Pathogenesis, classification, and treatment of myelodysplastic syndromes (MDS)
    Valent, P
    Wimazal, F
    Schwarzinger, I
    Sperr, WR
    Geissler, K
    WIENER KLINISCHE WOCHENSCHRIFT, 2003, 115 (13-14) : 515 - 536
  • [5] Myelodysplastic syndromes (MDS)
    Reinhard Stauder
    memo - Magazine of European Medical Oncology, 2009, 2 (2) : 108 - 109
  • [6] Myelodysplastic syndromes (MDS)
    Stauder, R.
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2009, 2 (02) : 108 - 109
  • [7] Myelodysplastic syndromes (MDS)
    Germing, U.
    Kuendgen, A.
    Haas, R.
    Gattermann, N.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2012, 137 (05) : 183 - 185
  • [8] Myelodysplastic syndromes (MDS)
    Burgstaller S.
    memo - Magazine of European Medical Oncology, 2014, 7 (3) : 134 - 137
  • [9] BESTATIN TREATMENT OF MYELODYSPLASTIC SYNDROMES (MDS) AND THE EFFECTS OF BESTATIN ON HEMATOPOIESIS IN MDS
    UZUKA, Y
    SAITO, Y
    ACTA ONCOLOGICA, 1990, 29 (06) : 803 - 807
  • [10] Application of the international scoring system (IPSS) for myelodysplastic syndromes (MDS).
    Maes, B
    Meeus, P
    Bijnens, L
    Boogaerts, M
    Hagemeijer, A
    De Wolf-Peeters, C
    Verhoef, F
    BLOOD, 1998, 92 (10) : 252B - 253B
12345